Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
Metronomic chemotherapy (MC) is the frequent, regular administration of drug doses designed to maintain a low, but active, range of concentrations of chemotherapeutic drugs, during prolonged periods of time without inducing excessive toxicities. To date, more than 400,000 children and adolescents un...
Main Authors: | Marta Banchi, Elisabetta Fini, Stefania Crucitta, Guido Bocci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/21/6254 |
Similar Items
-
Metronomic chemotherapy regimens in oncology
by: M. Yu. Fedyanin, et al.
Published: (2016-04-01) -
Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers
by: Kiran Kumar, et al.
Published: (2020-01-01) -
Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives
by: Vijay Kumar Panthi, et al.
Published: (2023-04-01) -
Metronomic Chemotherapy
by: Marina Elena Cazzaniga, et al.
Published: (2021-05-01) -
Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature
by: Benjamin Carcamo, et al.
Published: (2022-05-01)